Gastro-oesophageal Reflux Disease Trial, Recruiting NCT07635836 Sponsor: Qilu Hospital of Shandong University Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT07635836
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been confirmed through a biopsy to have a specific type of stomach cancer called gastric adenocarcinoma
  • People whose cancer is located in the upper part of the stomach, or at the junction where the food pipe meets the stomach (a specific category called Siewert type II or III), and whose cancer is at an early-to-moderate stage that has not spread to distant parts of the body
  • People aged between 18 and 75 years who are generally able to carry out daily activities (with a general health rating of 0–2 on a standard medical scale)
  • People who are planned to have surgery and, based on pre-surgery assessment, are considered suitable for one of two specific surgical reconstruction methods
  • People whose liver, kidneys, heart, lungs, and brain are functioning adequately, and who do not have serious active infections or uncontrolled long-term illnesses

Who may not be able to join:

  • People who have another type of cancer, or who have serious long-term conditions such as severe diabetes, significant kidney disease, or advanced liver disease
  • People who have been diagnosed before surgery with a condition called Barrett's esophagus (a change in the lining of the food pipe)
  • People who have significant malnutrition before surgery, based on specific protein levels measured in the blood being too low
  • People who have had previous surgery on the upper abdomen, have a structural abnormality of the digestive tract, or have a diagnosed psychiatric condition
  • People who have been diagnosed before surgery with a condition that affects the normal muscle movement at the entrance of the stomach (such as achalasia)
  • People who are unlikely to be able to cooperate with or complete the follow-up tests and examinations required after surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618560085120

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Qilu Hospital of Shandong University
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
1 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of postoperative reflux esophagitis; Severity of reflux esophagitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov